SLC7A11 Is Identified as an Oncogenic Driver in PTC In order to examine the expression of SLC7A11 in PTC and its potential clinical significance, 86 cases of tumor and corresponding noncancerous tissue from PTC patients were evaluated
Researchers from Torontos Sinai Health have published a study that sheds light on a central mystery for scientists studying the liver benefits of drugs such as Ozempic and Wegovy: how exactly they improve liver health, even in patients who dont lose weight
Summary: Weight gain on Ozempic can occur due to medication interactions, underlying endocrine conditions, fluid retention, dietary compensation, subtherapeutic dosing, or metabolic adaptation despite semaglutide's typical weight-reducing effects
Health system specialty pharmacies provide comprehensive support to help patients stay on track with their treatment plans
The mechanism involves upregulation of matrix metalloproteinases (MMPs) and their inhibitors, which remodel collagen in a more organized way than unassisted healing